Showing results (21-30 of 24) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
BMC Cancer|May 14, 2024
Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinomaYongqiang Xiao, Wei Deng, Laihui Luo, et al.Medicine|March 22, 2018
Situs inversus totalis with solid pseudopapillary pancreatic tumor: A case report and review of literatureDeng Xiang, Jiannan He, Zimeng Fan, et al.Frontiers in Oncology|October 14, 2022
Hepatic arterial infusion chemotherapy combined with PD-1 inhibitors and tyrosine kinase inhibitors for unresectable hepatocellular carcinoma: A tertiary medical center experienceLaihui Luo, Yongqiang Xiao, Guoqing Zhu, et al.BMC Cancer|April 25, 2025
The safety and efficacy of tyrosine kinase inhibitors and programmed cell death protein- 1 inhibitors combined with HAIC/TACE in the treatment of recurrent unresectable hepatocellular carcinomaWei Deng, Jin Xie, Tao Wang, et al.Pageof 3